POAI: Predictive Oncology Inc. Common Stock Company Profile & Statistics

About

Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.

Info & Links

CEO

Raymond F. Vennare

Headquarters

91 43RD STREET,SUITE 110
PITTSBURGH, PA 15201, UNITED STATES

Auditor

Baker Tilly US, LLP

Share holders

155

Employees

Predictive Oncology Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

9.70M

Enterprise Value

6.82M

Enterprise Value/EBITDA(ttm)

-0.52

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

7.29

Price to Book(mrq)

4.98

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

43.67%

Operating Margin(ttm)

-953.48%

Profit Margin(ttm)

-993.13%

Return on Equity(ttm)

-286.30%

Return on Invested Capital(ttm)

-344.90%

Return on Assets(ttm)

-122.11%

Income Statement

Revenue(ttm)

1.42M

Revenue Per Share(ttm)

0.21

Gross Profit(ttm)

623.20K

EBITDA(ttm)³

-13.01M

Net Income Available to Common(ttm)

-13.97M

Diluted EPS(ttm)

-3.05

Share Statistics

Beta (5Y Monthly)

1.25

52-Week Change

-59.95%

S&P 500 52-Week Change

18.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

6.67M

Dividend Yield

0.00%

Float⁴

6.44M

% Held by Insiders

3.44%

% Held by Institutions

9.04%

Balance Sheet

Total Cash(mrq)

3.08M

Total Cash Per Share(mrq)

0.46

Total Debt(mrq)

195.80K

Total Debt/Equity(mrq)

9.95%

Current Ratio(mrq)

1.20%

Quick Ratio(mrq)

1.06%

Book Value Per Share(mrq)

0.29

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.39

Free Cash Flow(ytd)

-8.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

POAI

Predictive Oncology Inc. Common Stock

Predictive Oncology Inc. Common Stock Profile